Navigation Links
Cataract Surgery to Eliminate Reading Glasses?

Improvements in the lenses implanted in the eye during cataract surgery have led to a new—and controversial—surgical option for people with presbyopia, a common form// of farsightedness that typically develops in middle age. But a new report from Harvard Medical School urges people considering this operation to weigh its risks, as well as its benefits.

The recently developed implantable variable-focus lenses, which enable people to see objects at varying distances by shifting their eyes slightly, are currently FDA-approved only for patients undergoing cataract surgery. But some ophthalmologists are also implanting them into the eyes of people without cataracts in order to correct presbyopia. This requires removing the eyes’ natural lenses, as is done in cataract surgery.

Preventing and Treating Eye Disease urges consumers to keep two things in mind before undergoing this surgery for presbyopia. First, it will not be covered by insurance unless you also have cataracts, and the cost can be $5,000 or more for each eye. Second, many ophthalmologists are reluctant to perform this procedure in people without cataracts because of the risks involved in any eye operation, as well as lack of information about long-term safety and effectiveness.

Risks of the operation include a very small chance of infection that may lead to blindness. It’s also important to understand that this surgery will not produce clear 20/20 vision.

Source-Newswise
RM
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Airlines Pilot At Heightened Risk Of Having Cataracts
3. Understanding The Relationship With Diet And Cataract
4. Good News For Cataract Patients
5. Cataract incidence high among people on a high carbohydrate diet.
6. Tea Found To Boost Insulin Production And Prevent Cataract
7. Scientist Identify 3 New Cataract Causing Genes
8. Indian Scientists Identify Cataract Causing Genes
9. Women Compensated For Losing Eye-Sight After Undergoing Cataract Operation
10. Post-operated Cataract Patients Lose Eyes
11. Bypass Heart Surgery Performed Without General Anesthesia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne ... signature product of her research center at Bio-Logic Aqua Research® Water Life Science®, ... the greatest number of sufferers of blindness. “We think that Nature’s Tears® EyeMist® ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... may give insight into why concussion rates are on the rise, say researchers ... Annual Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, has expanded ... healthcare services providers. , According to Peter Ohrenberger, sales director at Nastel, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a ... for everyone affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon ... off on July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using CDRH’s Medical Device ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          , Device makers ... It’s known as the “CY2016 Annual FDA Medical Device Quality System Data” report. ...
Breaking Medicine News(10 mins):
(Date:7/6/2017)... division of Diplomat Specialty Infusion Group, is celebrating a decade of empowering ... celebrate its anniversary, ThriveRx recently launched a redesigned website at thriverx.diplomat.is ... to create the best user experience for consumers and health care professionals. ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 years," ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
Breaking Medicine Technology: